The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2026

Filed:

Feb. 03, 2023
Applicant:

Research & Business Foundation Sungkyunkwan University, Suwon-si, KR;

Inventors:

Jae Hyung Park, Suwon-si, KR;

Dong Gyu Jo, Suwon-si, KR;

Sol Shin, Suwon-si, KR;

Jae Hoon Sul, Anyang-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/30 (2015.01); A61K 31/137 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
A61K 35/30 (2013.01); A61K 31/137 (2013.01); A61P 25/28 (2018.01);
Abstract

The present disclosure relates to a pharmaceutical composition for preventing or treating a brain disease, comprising a stem cell-derived exosome surface-modified with a compound capable of binding to dopamine receptors or L-amino acid transporters as an active ingredient. The stem cell-derived exosome according to the present disclosure selectively binds to dopamine receptors (D2) overexpressed as autoreceptors in dopaminergic neurons in the substantia nigra through surface modification. Thereby, local accumulation in dopaminergic neurons is possible. In addition, it was identified that the stem cell-derived exosome exhibited an excellent neuron protective effect and neuron death inhibitory effect. Accordingly, the surface-modified stem cell-derived exosome according to the present disclosure is expected to be usefully used as a composition for preventing or treating a brain disease including Parkinson's disease and Alzheimer's disease.


Find Patent Forward Citations

Park, Jae. (2026). Pharmaceutical composition for preventing or treating brain disease, comprising stem cell-derived exosome surface-modified with compound capable of binding to dopamine receptors or l-amino acid transporters (U.S. Patent No. 12622930). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12622930

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…